EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Impact of NOTCH3 Variant Location After First Stroke in CADASIL

Léa Aguilhon iD, Hugues Chabriat iD, Dominique Hervé, Stéphanie Guey, Sophie Tezenas Du Montcel, Juliette Ortholand

Annals of Clinical and Translational Neurology · 06.05.2026

DOI: 10.1002/acn3.70424 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 06.05.2026. Verfasst von Léa Aguilhon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, CNRS, Inria, Inserm, AP-HP, Hôpital de la Pitié Salpêtrière, Paris, France. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministère de la Santé, Agence Nationale de la Recherche, European Joint Program for Rare Disease - Horizon H2020 - CADANHIS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Despite its monogenic origin, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy exhibits marked variability in clinical expression and severity. Variants in the NOTCH3 gene, within epidermal growth factor‐like repeat domains 1–6 or 7–34, are known to influence disease onset, but their impact on long‐term progression remains unclear. This study assesses mutation location effects on post‐first stroke clinical trajectories.

Methods

Clinical data from a large cohort were analyzed (Patients EGFR 1–6 mutation group n = 210 and 7–34 mutation group n = 116) with target emulated trial framework. To study the impact of mutation location on stroke recurrence, disability (modified Rankin score ≥ 3) and mortality, following a first stroke event. Propensity score matching was used to balance covariates between mutation location groups and principal stratification to consider truncation by death. Events occurrence differences were compared using Restricted Mean Survival Time at 2, 5, 10 and 15 years.

Results

At first stroke, patients with mutation in domains 1–6 were younger than those in the 7–34 mutation group (49.51 ± 7.4 vs. 55.00 ± 7.4 years). Ten years after first stroke event, mortality occurred slightly later in the 7–34 group (9.63 [9.33–9.92] vs. 9.11 [8.71–9.52] years, p = 0.04), also at 15 years (14.0 [13.42–14.63] vs. 12.4 [11.62–13.24] years; p = 0.002). Second stroke occurrence did not differ between groups. Time beyond modified Rankin of 3 slightly differed between groups at 5 and 10 years, with a difference of 0.22 [0.01–0.044] and 0.72 [0.14–1.30] year respectively ( p = 0.044 and 0.017).

Interpretation

Although NOTCH3 variants location influences the delay to the first stroke, it has no or little impact on the recurrence of stroke, risk of disability and death after the first stroke manifestation.

Schlagwörter

Stichwörter der Autor:innen

CADASILNOTCH3principal stratificationstroke

Autor:innen und Institutionen

  • Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, CNRS, Inria, Inserm, AP-HP, Hôpital de la Pitié Salpêtrière, Paris, France.
  • GENOVASC, INSERM U1127, Paris Brain Institute (Institut du Cerveau-ICM), Paris, France.
  • Centre de Référence National des Maladies Rares des Vaisseaux du Cerveau et de L'œil (CERVCO) and Centre Neurovascular Translationnel (CNVT), FHU-NeuroVasc-2030, Hopital Lariboisiére APHP, Paris, France.
  • Université Paris-Cité, Paris, France.

ORCID-Profile: Léa Aguilhon, Hugues Chabriat

Förderung

  • Ministère de la Santé
  • Agence Nationale de la Recherche
  • European Joint Program for Rare Disease - Horizon H2020 - CADANHIS

Zitieren

APA

Aguilhon, L., Chabriat, H., Hervé, D., Guey, S., Du Montcel, S. T., & Ortholand, J. (2026). Clinical Impact of NOTCH3 Variant Location After First Stroke in CADASIL. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70424

Vancouver

Aguilhon L, Chabriat H, Hervé D, Guey S, Du Montcel ST, Ortholand J. Clinical Impact of NOTCH3 Variant Location After First Stroke in CADASIL. Annals of Clinical and Translational Neurology. 2026. doi:10.1002/acn3.70424

BibTeX
@article{Aguilhon2026,
  author = {Aguilhon, Léa and Chabriat, Hugues and Hervé, Dominique and Guey, Stéphanie and Du Montcel, Sophie Tezenas and Ortholand, Juliette},
  title = {Clinical Impact of NOTCH3 Variant Location After First Stroke in CADASIL},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2026},
  doi = {10.1002/acn3.70424}
}
Kostenlos starten →